Akèy › Kansè Vezik ki pa envazif miskilè
Etid klinik pou Kansè Vezik ki pa envazif miskilè ap rekrite nan Etazini
33 etid pou Kansè Vezik ki pa envazif miskilè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY10 etid
- Columbus, OH10 etid
- Dallas, TX10 etid
- Edison, NJ9 etid
- Myrtle Beach, SC9 etid
- Syracuse, NY8 etid
- Nashville, TN8 etid
- Baltimore, MD8 etid
- Philadelphia, PA7 etid
- Birmingham, AL7 etid
- Houston, TX7 etid
- Indianapolis, IN7 etid
- Atlanta, GA7 etid
- Austin, TX6 etid
- Los Angeles, CA6 etid
- Boston, MA6 etid
- Little Rock, AR6 etid
- San Antonio, TX6 etid
- St. Louis, MO6 etid
- Chicago, IL6 etid
- Bakersfield, CA5 etid
- Memphis, TN5 etid
- Cicero, IL5 etid
- Tampa, FL5 etid
- Durham, NC5 etid
- Staten Island, NY4 etid
- Greenburgh, NY4 etid
- East Norwalk, CT4 etid
- Queens, NY4 etid
- Seattle, WA4 etid
- Jacksonville, FL4 etid
- Pittsburgh, PA4 etid
- Lakewood, CO4 etid
- Kansas City, KS4 etid
- Washington, DC4 etid
- New Rochelle, NY3 etid
- Lafayette, LA3 etid
- Cincinnati, OH3 etid
- Phoenix, AZ3 etid
- Arlington, TX3 etid
Pa eta
- Alabama7 etid
- Arizona9 etid
- Arkansas6 etid
- Colorado5 etid
- Distrik Columbia4 etid
- Florid15 etid
- Georgia7 etid
- Illinois11 etid
- Indiana8 etid
- Iowa3 etid
- Kalifòni15 etid
- Kansas4 etid
- Lwizyàn5 etid
- Maryland8 etid
- Massachusetts10 etid
- Michigan7 etid
- Minnesota4 etid
- Missouri7 etid
- New Jersey9 etid
- New York16 etid
- North Carolina6 etid
- Ohio13 etid
- Oregon3 etid
- Pennsylvania9 etid
- South Carolina12 etid
- Tennessee10 etid
- Texas15 etid
- Virginia6 etid
- Washington5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06733363Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07480356A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
Ap rekriteFaz 3
Laj 21 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06929286FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05519241Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05126472Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07225127Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Apr 17, 2026 · NCT07322263In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06704191Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.